Noemi Muszbek
Oxford, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Overall survival in the UK in mycosis fungoides or Sézary syndrome cutaneous T-cell lymphoma: comparative effectiveness of mogamulizumab versus current standard of care.
Journal: Journal of comparative effectiveness research
Published: August 29, 2023
Cost-utility analysis of mogamulizumab in advanced mycosis fungoides and Sézary syndrome cutaneous T-cell lymphoma.
Journal: Journal of comparative effectiveness research
Published: June 20, 2023
Adjusting for treatment crossover in the MAVORIC trial: survival in advanced mycosis fungoides and Sézary syndrome.
Journal: Journal of comparative effectiveness research
Published: June 09, 2022
Changes in treatment pattern and costs in advanced hepatocellular carcinoma (HCC).
Journal: Expert review of pharmacoeconomics & outcomes research
Published: September 07, 2021
Cost-utility analysis of selective internal radiation therapy with Y-90 resin microspheres in hepatocellular carcinoma.
Journal: Future oncology (London, England)
Published: November 23, 2020
Cost-Effectiveness of Sarilumab Added to Methotrexate in the Treatment of Adult Patients with Moderately to Severely Active Rheumatoid Arthritis Who Have Inadequate Response or Intolerance to Tumor Necrosis Factor Inhibitors.
Journal: Journal of managed care & specialty pharmacy
Published: October 31, 2019
Economic Evaluation of Sarilumab in the Treatment of Adult Patients with Moderately-to-Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic Disease-Modifying Antirheumatic Drugs.
Journal: Advances in therapy
Published: February 08, 2019
Cost-Effectiveness of Golimumab in Ankylosing Spondylitis from the UK Payer Perspective.
Journal: Rheumatology and therapy
Published: June 26, 2017
The Cost-effectiveness of Pixantrone for Third/Fourth-line Treatment of Aggressive Non-Hodgkin's Lymphoma.
Journal: Clinical therapeutics
Published: October 19, 2015
Comparative healthcare-associated costs of methicillin-resistant Staphylococcus aureus bacteraemia-infective endocarditis treated with either daptomycin or vancomycin.
Journal: International journal of antimicrobial agents
Published: October 16, 2015
The Life and Death of the End of Life Treatment Appraisal Criteria in Nice Technology Appraisals?
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: November 01, 2014
Last Updated: 09/26/2026